Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation | Zendy

Kang-Ling Wang | Zendy; Gregory Y.H. Lip | Zendy; ShingJong Lin | Zendy; ChernEn Chiang | Zendy

Open Access

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

Author(s) -

Kang-Ling Wang,

Gregory Y.H. Lip,

ShingJong Lin,

ChernEn Chiang

Publication year - 2015

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.009947

Subject(s) - medicine , vitamin k antagonist , atrial fibrillation , stroke (engine) , antagonist , dabigatran , cardiology , vitamin k , apixaban , rivaroxaban , warfarin , receptor , mechanical engineering , engineering

The use of vitamin K antagonists (VKAs), the cornerstone treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived risk of serious bleeding in Asia. Non-VKA oral anticoagulants (NOACs) are safer alternatives. Here, we evaluate performance differences of NOACs between Asians and non-Asians.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research